Chemoinformaics analysis of 12-nor-Preziza-7(15)-en-2-one
| Molecular Weight | 204.313 | nRot | 0 |
| Heavy Atom Molecular Weight | 184.153 | nRig | 15 |
| Exact Molecular Weight | 204.151 | nRing | 3 |
| Solubility: LogS | -3.995 | nHRing | 0 |
| Solubility: LogP | 2.864 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 37.5179 |
| nHD | 0 | BPOL | 20.9321 |
| QED | 0.553 |
| Synth | 5.461 |
| Natural Product Likeliness | 2.845 |
| NR-PPAR-gamma | 0.558 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.018 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.694 |
| MDCK | 0.0000195 |
| BBB | 0.605 |
| PPB | 0.702268 |
| VDSS | 1.103 |
| FU | 0.288691 |
| CYP1A2-inh | 0.053 |
| CYP1A2-sub | 0.865 |
| CYP2c19-inh | 0.284 |
| CYP2c19-sub | 0.928 |
| CYP2c9-inh | 0.14 |
| CYP2c9-sub | 0.865 |
| CYP2d6-inh | 0.019 |
| CYP2d6-sub | 0.888 |
| CYP3a4-inh | 0.072 |
| CYP3a4-sub | 0.276 |
| CL | 11.184 |
| T12 | 0.237 |
| hERG | 0.006 |
| Ames | 0.024 |
| ROA | 0.151 |
| SkinSen | 0.032 |
| Carcinogencity | 0.438 |
| EI | 0.459 |
| Respiratory | 0.944 |
| NR-Aromatase | 0.253 |
| Antiviral | Yes |
| Prediction | 0.791266 |